Rare Diseases

...

The botulinum toxin market is one of the most highly regulated areas of the pharmaceutical industry in 2025. Botulinum toxin products in the United States are classified by the U.S. Food and Drug Administration as prescription biologics and...

The Eosinophilic Esophagitis (EoE) disease treatment market comprises a specialized sector of the pharmaceutical and biotechnology industries dedicated to the management of a chronic, immune-mediated inflammatory disorder of the esophagus. ...

The palliative care market comprises specialized medical care services designed to optimize the quality of life for patients and families facing life-threatening and chronic progressive illnesses. Core service categories include inpatient h...

The Idiopathic Pulmonary Fibrosis Diagnostic And Treatment Market is expected to grow from USD 5.917 billion in 2025 to USD 8.549 billion in 2030, at a CAGR of 7.64%. This research study examines the idiopathic pulmonary fibrosis diagnosti...

The intracranial aneurysm market is expected to grow at a CAGR of 8.41% from US$1.411 billion in 2022 to US$2.484 billion in 2029. A brain aneurysm is a ballooning that develops from a weak spot in the wall of a blood artery in the brain (...

The HPV-associated disorders market is expected to witness significant growth during the forecasted period. More than 100 viruses make up the human papillomavirus family, 14 of which can lead to cancer. HPV is the reason for almost all occ...

The Cushing's Syndrome Diagnostic And Treatment Market is expected to grow from US$402.859 million in 2025 to US$561.754 million in 2030, at a CAGR of 6.88%. Cushing’s disease is a condition characterised by the presence of excess st...

Disruptive Behavior Disorder Treatment Market is anticipated to rise at a 5.36% CAGR, increasing from USD 1.508 billion in 2025 to USD 1.957 billion by 2030. Disruptive behavior disorders are a group of disorders with symptoms like frequen...

Retinal Disorder Treatment Market is set to grow at a 6.71% CAGR, growing from USD 16.368 billion in 2025 to USD 22.652 billion by 2030. The retinal disorder treatment market is focused on developing treatments for various retinal diseases...

Onychomycosis Market is anticipated to increase at a 4.56% CAGR, growing from USD 4.733 billion in 2025 to USD 5.915 billion by 2030. Onychomycosis is a contagious disease that influences the nails of the fingers and toes. The onychomycosi...

Epidermolysis Bullosa Care and Treatment Market Size: The epidermolysis bullosa care and treatment market will grow at a CAGR of 7.10% to be valued at US$3861.27 billion in 2030 from US$2740.459 billion in 2025. Epidermolysis Bullosa ...